100 related articles for article (PubMed ID: 1318461)
1. Evaluation of the dysmyelopoiesis in 336 patients with de novo acute myeloid leukemia: major importance of dysgranulopoiesis for remission and survival.
Goasguen JE; Matsuo T; Cox C; Bennett JM
Leukemia; 1992 Jun; 6(6):520-5. PubMed ID: 1318461
[TBL] [Abstract][Full Text] [Related]
2. De novo AML with dysplastic hematopoiesis: cytogenetic and prognostic significance.
Gahn B; Haase D; Unterhalt M; Drescher M; Schoch C; Fonatsch C; Terstappen LW; Hiddemann W; Büchner T; Bennett JM; Wörmann B
Leukemia; 1996 Jun; 10(6):946-51. PubMed ID: 8667650
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of dysplastic features of hematopoiesis in patients with de novo acute myelogenous leukemia.
Kahl C; Florschütz A; Müller G; Jentsch-Ullrich K; Arland M; Leuner S; Franke A; Höffkes HG
Ann Hematol; 1997 Sep; 75(3):91-4. PubMed ID: 9368477
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and treatment strategy for de novo AML with trilineage myelodysplasia].
Kuriyama K
Rinsho Ketsueki; 1994 Mar; 35(3):267-71. PubMed ID: 8158847
[TBL] [Abstract][Full Text] [Related]
5. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.
Lai JL; Preudhomme C; Zandecki M; Flactif M; Vanrumbeke M; Lepelley P; Wattel E; Fenaux P
Leukemia; 1995 Mar; 9(3):370-81. PubMed ID: 7885035
[TBL] [Abstract][Full Text] [Related]
6. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
[TBL] [Abstract][Full Text] [Related]
7. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
Fruchart C; Lenormand B; Bastard C; Boulet D; Lesesve JF; Callat MP; Stamatoullas A; Monconduit M; Tilly H
Am J Hematol; 1996 Nov; 53(3):175-80. PubMed ID: 8895688
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
[TBL] [Abstract][Full Text] [Related]
9. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
Bloomfield CD; Lawrence D; Byrd JC; Carroll A; Pettenati MJ; Tantravahi R; Patil SR; Davey FR; Berg DT; Schiffer CA; Arthur DC; Mayer RJ
Cancer Res; 1998 Sep; 58(18):4173-9. PubMed ID: 9751631
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of micromegakaryocytes in de novo AML].
Kobayashi S; Seki K; Katayama N; Akiba C; Yamamoto T; Sakai K; Yamaguchi M; Maruta A; Noguchi T; Ogawa K
Rinsho Ketsueki; 1993 Mar; 34(3):313-20. PubMed ID: 8479083
[TBL] [Abstract][Full Text] [Related]
11. Clinical and cytogenetic correlations of abnormal megakaryocytopoiesis in patients with acute leukemia and chronic myelogenous leukemia in blast crisis.
Lee EJ; Schiffer CA; Tomiyasu T; Testa JR
Leukemia; 1990 May; 4(5):350-3. PubMed ID: 2388480
[TBL] [Abstract][Full Text] [Related]
12. High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF).
Estey EH; Kantarjian HM; O'Brien S; Kornblau S; Andreeff M; Beran M; Pierce S; Keating M
Cytokines Mol Ther; 1995 Mar; 1(1):21-8. PubMed ID: 9384660
[TBL] [Abstract][Full Text] [Related]
13. [Long-term results of the UHKT-911 study of adult patients under 65 years of age with de novo acute myeloid leukemias without favorable karyotypes].
Lemez P; Vítek A; Michalová K; Zemanová Z; Lukásová M
Vnitr Lek; 2003 Mar; 49(3):174-80. PubMed ID: 12728590
[TBL] [Abstract][Full Text] [Related]
14. Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia: analysis of prognostic factors.
Stasi R; Venditti A; Del Poeta G; Aronica G; Dentamaro T; Cecconi M; Stipa E; Scimò MT; Masi M; Amadori S
Cancer; 1996 Jun; 77(12):2476-88. PubMed ID: 8640696
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness analysis of HA based triple-drug regimen as induction chemotherapy in the treatment of acute myeloid leukemia and its relationship with karyotype].
Mi YC; Xue YP; Yu WJ; Liu SH; Zhao YZ; Meng QX; Bian SG; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):705-9. PubMed ID: 16620570
[TBL] [Abstract][Full Text] [Related]
16. [Long-term survival results according to cytogenetic risk in patients with acute myeloid leukemia--singl center experience].
Piatkowska-Jakubas B; Mensah-Glanowska P; Salamańczuk Z; Skotnicki AB
Przegl Lek; 2011; 68(6):291-5. PubMed ID: 22039664
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and cytogenetics studies on acute myeloid leukemia with abnormality of chromosome 11].
Lu Y; Xu W; Chen Z; Lou J; Jin J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):583-5. PubMed ID: 18841578
[TBL] [Abstract][Full Text] [Related]
18. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
Mauritzson N; Albin M; Rylander L; Billström R; Ahlgren T; Mikoczy Z; Björk J; Strömberg U; Nilsson PG; Mitelman F; Hagmar L; Johansson B
Leukemia; 2002 Dec; 16(12):2366-78. PubMed ID: 12454741
[TBL] [Abstract][Full Text] [Related]
19. Newly diagnosed adult AML and MPAL patients frequently show clonal residual hematopoiesis.
Fernandez C; Santos-Silva MC; López A; Matarraz S; Jara-Acevedo M; Ciudad J; Gutierrez ML; Sánchez ML; Salvador-Osuna C; Berruezo MJ; Díaz-Arias JÁ; Palomo-Hernández AM; Colado E; González N; Gallardo D; Asensio A; García-Sánchez R; Saldaña R; Cerveró C; Carboné-Bañeres A; Gutierrez O; Orfao A
Leukemia; 2013 Nov; 27(11):2149-56. PubMed ID: 23579575
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of dysmyelopoietic features in de novo acute myeloid leukaemia: a report on 132 patients.
Estienne MH; Fenaux P; Preudhomme C; Lai JL; Zandecki M; Lepelley P; Cosson A
Clin Lab Haematol; 1990; 12(1):57-65. PubMed ID: 2344717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
